Theolytics

Developer of oncolytic adenovirus for the treatment of cancer

placeHeadington, England, United Kingdom calendar_todayFounded 2017 groups26 employees language theolytics.com

Registered entities

Innovation

15 patent families — focus: Chemistry & metallurgy, Human necessities; filing pace accelerating. Cited 104 times.

YearFilings
20191
20203
20211
20231
20247
20254
20264

Social engagement

Social engagement: 5K social following, 9 posts in the last 12 months — below the industry typical range.

Investor mix

13 investors on record; lead investors include Sound Bioventures, Taiho Ventures, Epidarex Capital, Oxford Science Enterprises.

Investor typeCountShare
Venture capital538%
Angel & family office18%
Accelerator & incubator18%
Other / undisclosed646%

Hiring activity

Hires occasionally

1 role tracked across 1 of the last 12 months

15 May 2026 · Associate Scientist, Project Manager · Oxford

Based on job postings tracked across public sources.

Recent activity

19 Jun 2026
Event
BIO2026
15 Jun 2026
Event
Cambridge Wide Open Week - A week of life sciences @ the home of life sciences
15 Jun 2026
Event
Longwood Healthcare Leaders forum
Coming soon